← Markets · Watchlists · Compare · News
VIR (VIR)
Delayed quote with key statistics, history chart, and news that mentions or impacts this name.
Sign in to jump from your saved watchlists.
VIRNASDAQLive delayed
$8.90
+0.26+3.01%
SourceCNBCAs ofJul 30, 2026, 12:00 AM
Delayed market data from CNBC. Not investment advice.
Key statistics
Delayed fundamentals for VIR · Finnhub.
- Market cap
- $1.50B
- P/E (TTM)
- -
- EPS (TTM)
- -$3.1639
- Div. yield
- -
- 52-week range
- $4.155 - $11.66
- Volume
- -
- Avg volume
- 1.58M
Price history
OHLC candles for VIR · 3mo · 1day · Twelve Data · delayed · EMA / RSI
-17.82%periodDirect mentions, stories that impact this name, and related market themes, with Impact Analysis on each headline.
DirectHigh impactGlobalMostly neutralGoogle News
Vir Das reveals 'Everything went away' after two Indias controversy; says he's still 'banned' in Madhya PVir Das reveals 'Everything went away' after two Indias controversy; says he's still 'banned' in Madhya P The Times of IndiaBroad market headline - check whether risk appetite shifts.
Watch: .SPX · .FTSE · .N225 · @CL.1
DirectHigh impactGoogle News
Vir Biotechnology (VIR) Expected to Post Earnings on WednesdayDirectHigh impactGoogle News
SB Investment Advisers UK Ltd. Sells 2,168,884 Shares of Vir Biotechnology, Inc. $VIRDirectHigh impactGoogle News
ADAR1 Capital Management LLC Invests $24.59 Million in Vir Biotechnology, Inc. $VIRDirectHigh impactGoogle News
Eversept Partners LP Takes $2.24 Million Position in Vir Biotechnology, Inc. $VIRDirectHigh impactGoogle News
Empyrean Capital Partners LP Invests $4.73 Million in Vir Biotechnology, Inc. $VIRDirectHigh impactGoogle News
VIR|Vir Biotechnology Inc|Price:8.655|Chg%:-0.196DirectHigh impactGoogle News
Vir Biotechnology, Inc. (VIR) Q1 2026 Earnings Report - Results, Call & Slides